Prof A Vathsala is a Senior Consultant and Head, Division of Nephrology, Department of Medicine at the National University of Singapore and Co-Director of the National University Centre for Organ Transplantation at the National University Health System.


She graduated with a Bachelors of Science in the Premedical Curriculum from Auburn University, Auburn, Alabama, studied Medicine at Vanderbilt University School of Medicine, Nashville, Tennessee, USA and completed her training in Internal Medicine in Singapore.  She obtained her Membership in the Royal College of Physicians (United Kingdom) followed by additional training in Renal Medicine at the Singapore General Hospital and Kidney Transplantation at the University of Houston, Texas and the Cornell University School of Medicine, USA.  She is a Fellow of the Royal College of Physicians of Edinburgh and a Fellow, Academy of Medicine (Singapore).


She was the founding President of the Society of Transplantation (Singapore) and Current President of the Asian Society of Transplantation. She holds executive positions in the international Transplantation Society as a Member of its Ethics Committee. She is also a member of the Board of Directors of the National Kidney Foundation, Singapore. She has research interests in many areas in the field of transplantation including cellular and molecular signatures of chronic allograft survival, immunosuppression, pharmacokinetics and pharmacogenomics and has a special interest in preventive nephrology, lupus nephritis and glomerulonephritis.


(United States)

Dr Stephen Boorjian is a Professor of Urology, Vice Chair of Research for the Department of Urology, and the Director of the Urologic Oncology Fellowship at Mayo Clinic.  He received his MD from Harvard Medical School, and was a resident in Urology at New York Presbyterian Hospital-Weill Cornell Medical Center.  He subsequently completed a fellowship in Urologic Oncology at Mayo Clinic.  His research interests include optimising the management for patients with high-risk prostate cancer, evaluating the outcomes among patients undergoing radical cystectomy for bladder cancer, and improving surgical therapy for advanced renal cell carcinoma.  Dr Boorjian has co-authored over 250 manuscripts and book chapters, and was recognised as “Teacher of the Year” in Urology for 2012 by the Mayo Clinic Fellows’ Association.  Moreover, he has twice won the Best Reviewer Award and once won the Outstanding Reviewer Award from the Journal of Urology for his reviews in Prostate Cancer and in Basic Science, and has been awarded the Reviewer of the Month as well as Reviewer of the Year by European Urology, where he is now an Associate Editor.  He was recognised with the 2014 Young Urologist of the Year award from the AUA.  He is a member of the NCCN Guidelines Panels for Bladder Cancer and Penile Cancer, and serves on the AUA Non-Muscle Invasive Bladder Cancer Guidelines Panel.

Dr CHONG Kian Tai


In his clinical practice at Tan Tock Seng Hospital in Singapore, Dr Chong Kian Tai concentrates on Urology Cancers. He is a board-certified Urologist and surgeon who manages complex Urologic Oncology issues, and operates using open, laparoscopic and da-Vinci robotic operating system.

Dr Chong completed his full-time Clinical Urologic-Oncology Fellowship at the Memorial-Sloan Kettering Cancer Center (MSKCC) in New York, USA. His key professional interests are the prevention, diagnosis, treatment and management of prostate cancer, kidney cancer, bladder cancer, testis cancer and penile cancer.

Currently Dr Chong is the Consultant, Adjunct Assistant Professor, co-Director of Urologic Oncology and Director of Research in the Department of Urology. He also manages the prospective Urology Cancer clinical databases and Tissue Repository in Tan Tock Seng Hospital.

As a founding member of the Singapore Urological Cancer Consortium, Dr Chong leads several research teams and is involved in Prostate, Kidney, Bladder, Testicular and Penile Cancer research. These projects include precision medicine, biomolecular, nanoparticle, bioimaging and novel biomedical device studies.

In supporting holistic care for urological cancer patients, he is also the Chairman for the Urology Cancer Multi-disciplinary Tumour Board, Urology Cancer Support Programme, Advanced Care Planning team and TTSH Prostate Cancer Support Group for patients and their family.

Dr Peggy CHU

(Hong Kong SAR)

Dr Peggy Chu is the consultant urologist in Tuen Mun Hospital and the past president of the Hong Kong Urological Association, 2010-2012.

Dr Chu received her medical degree from the University of Hong Kong. She then received her urology training from Queen Elizabeth Hospital. Her overseas training took place at the Institute of Urology, University College London, in 1996. After coming back from London, she continued to work in Queen Elizabeth Hospital until 2006; since then she continued her career in Tuen Mun Hospital.

Dr Peggy Chu is specialized in reconstructive, neuro and female urology. She led the team, including urologists from Princess Margaret Hospital and toxicologists from United Christian Hospital, which reported the first 10 cases in Hong Kong with contracted bladder and upper urinary tract damage associated with ketamine abuse. This discovery has raised the Hong Kong Government’s and the community’s awareness of the social problems associated with Ketamine abuse. She also provided an affidavit to the Hong Kong High Court, thus leading to more stringent guidelines on sentencing of ketamine abuse since June 2008. Dr Chu received the Outstanding Staff Award from Hong Kong Hospital Authority in 2009.

Dr Benjamin Canales graduated in 2001 from LSU Medical School in New Orleans. He completed urology residency and a combined AUA Foundation Research Scholar/Minimally Invasive Urology Fellowship at the University of Minnesota with a special focus on the basic science mechanisms involved in kidney stone formation. In 2007, he joined the urology faculty at the University of Florida and has used NIH funding to develop new animal models of stone disease and novel therapeutic approaches for nephrolithiasis. He received the 2011-2015 AUA Care Foundation Rising Star in Urology Award and the 2016 AUA Gold Cystoscope award for his efforts. In addition to his clinical interests in stone disease, he performs minimally invasive surgery for renal tumors and obstruction, including laparoscopic nephrectomy, partial nephrectomy, and pyeloplasty.

Dr Benjamin CANALES

(United States)


(United States)

Dr Matthew Cooperberg received his undergraduate training from Dartmouth College, where he earned a degree in English with high honours. He then enrolled in Yale University's MD, MPH program, concurrently earning an MPH with a concentration in Health Policy from the School of Epidemiology and Public Health, and a MD from the School of Medicine. He completed his General Surgery and Urology training at the University of California, San Francisco, and subsequently continued at UCSF to complete a fellowship in Urologic Oncology under the guidance of Peter Carroll, MD, MPH. In 2009, Dr. Cooperberg was recruited to join the faculty at UCSF and the San Francisco Veterans Affairs Medical Center. Specializing in urologic cancer care, he is part of the multidisciplinary urologic oncology team of the UCSF Helen Diller Family Comprehensive Cancer Center, located primarily at the Mission Bay campus. He also maintains privileges at San Francisco General Hospital. In 2013, Cooperberg received the first Helen Diller Family Chair in Urology and a secondary appointment in the Department of Epidemiology and Biostatistics. In 2015 he won the American Urological Association Gold Cystoscope Award, given annually to one urologist for contributions to the field in the first 10 years of practice.

In April 2004, Shin Egawa was appointed the 6th chairman and Professor of Department of Urology, Jikei University School of Medicine. Presently, the Department of Urology, under Professor Egawa’s leadership, has 75 members (including 23 residents) serving at the Jikei University Hospital,

Three attached hospitals, and twelve affiliated hospitals. Its main clinical areas include urologic oncology, gynecological urology, pediatric urology, neurourology, and laparoscopic surgery. In research, its main fields of concentration are the study of proteomes in prostate cancer and gene therapy. With the world becoming increasingly globalized, the Department will promote even more active communication with fellow physicians in other countries on both the clinical and research fronts.



Prof FOO Keong Tatt


Dr Foo graduated from Singapore University in 1965 and obtained FRCS from the College of Surgeon of Edinburgh in 1971, and FAMS (Urology) 1991.


He is currently Emeritus Consultant Department of Urology at the Singapore General Hospital, having served as the Head of Department from 1988 to 2001.He is a Clinical Professor, YLL S o M, National University of Singapore, and Adjunct Professor, Duke-NUS medical School.


He is the Founder President of the Singapore Urological Association (President 1986 to 1989). He was the Secretary-General to the Urological Association of Asia 1998 to 2006.

He had served as Director of Asian School of Urology (2006-2010) and currently the Honorary Executive Director of the Urological Association of Asia (UAA) since 2010.He was the Vice-Chairman for the 5th International Consultation on BPH in Paris, July 2000 and was a member of the Steering Committee for the International Consultation on Urological Diseases (ICUD) (2000 to 2006).


He was conferred the honorary membership of the Malaysian Urological Association in 1999, the Wu Jieping Medical Foundation (China) trophy for his contributions to Urology in 2000, the Honorary membership of the Singapore Medical Association in 2007. He was accorded the Lifetime Achievment  Award by World Chinese Urological Society in May 2008, and the Karl Storze Endourological Award by the Endourological Society in December 2008. He received the Distinguished Career Award from the International Urological Society (SIU) in 2009. He was made the Honorary Fellow of the Sri Langka Urological Association in 2011.

He was conferred the Honorary membership of the European Urological Association, and the Outstanding Chinese Urologist, in 2015.


He was awarded the Public Administrative Medal (Silver) in 2001 by the President of Singapore. He has over 100 publications in Local, and International journals on BPH, Urinary Stone Diseases, Bladder Cancers and philosophy in Medicine.

Dr Henry HO

Associate Professor Henry HO is a senior consultant urologist in Singapore General Hospital.


He is a robotic and minimally invasive cancer urologist. He completed this fellowship in Europe with the University of Innsbruck, Austria. Under the tutelage of Professor Georg Bartsch, he was trained in robotic prostatectomy and robotic partial nephrectomy for kidney cancers.


He is the chairman for robotic surgery workgroup in Singapore General Hospital and a panel member of robotic-assisted surgery for Ministry of Health. He also did an endourology fellowship in Hamburg, Germany with Professor Andreas Gross. He is trained in endoscopic management of stones disease and laser prostatectomy.


As a surgeon-innovator, he is the director of medical technology office for Singhealth. He is one of the inventors for robotic device (Mono LisaTM Biobot Surgicals pte ltd) for transperineal prostate biopsy, which is safer and more accurate detection of prostate cancer. He leads in technology research and development with keen interest in kidney, prostate diseases and minimally invasive surgery. His latest grant is on a non-invasive treatment for benign prostate enlargement. He has won many awards, local and international.


Amongst his many peer-reviewed articles as the lead author, his most memorable is the prospective randomized trial that compared bipolar and monopolar TURP, published in the European Urology.


He is associate professor for DUKE-NUS post-graduate medical school and senior clinical teacher for Yong Loo-Lin medical school. He volunteers as the chairman of the prostate cancer survivorship program for Singapore Cancer Society.

Dr Tricia KUO


Dr Kuo is a Consultant with the Department of Urology at the Singapore General Hospital. She obtained her medical degree from the National University of Singapore in 2004. She completed her advanced traineeship in Urology in 2012. She is a member of the Singapore Urology Association (SUA). In addition to presenting at various local and international conferences, Dr Kuo has been actively involved in speaking at public talks and GP forums.   

In 2013, she was awarded a fellowship at the Royal Hallamshire Hospital in Sheffield (UK) with Prof CR Chapple, sub-specializing in Female Urology, Urodynamics and Reconstructive Urology. She has a keen interest in incontinence disorders, pelvic floor and other lower urinary tract disorders e.g. benign prostatic hyperplasia (BPH).  She is trained in sub-specialized procedures such as tapes/slings and artificial urinary sphincters for the treatment of both female and male incontinence, Botox™ treatment for overactive bladder, sacral nerve stimulation (SNS), posterior tibial nerve stimulation (PTNS) and reconstructive urology e.g. urethroplasty for urethral strictures and urethral diverticulum, vesico-vaginal fistula (VVF). 

Currently, she is the director of the Female and Reconstructive Urology service at the Department of Urology, Singapore General Hospital.

Dr Lee Fang Jann graduated with MBBS from the National University of Singapore in 2001. He completed his basic and advance training in General Urology in Singapore General Hospital. In 2010, he obtained Urology Specialty Accreditation from the Ministry of Health, Singapore. He was awarded a HMDP scholarship to pursue sub-specialty training in Renal and Pancreas Transplantation and trained as an Honorary Senior Clinical Fellow in the Oxford Transplantation Centre, United Kingdom. Dr Lee also sub-specialises in Andrology and is presently the Director of both the Renal Transplantation and Andrology services in SGH. Dr Lee is active in teaching and is a clinical faculty for both the Yong Loo  Lin School of Medicine, NUS and the Duke-NUS Graduate School of Medicine.

Dr LEE Fang Jann
Dr NG Foo Cheong

Dr Ng Foo Cheong is the Chief and Senior Consultant at the Department of Urology, Changi General Hospital, Singapore.  He is a member of the Medical Board and the Deputy Chairman of the Medical Audit Committee.  He is the Director of the Robotic Surgery Programme in CGH.  He holds an academic appointment as a Clinical Senior Lecturer at the Yong Loo Lin School of Medicine, National University of University.  He is a member of the Urology Residency Advisory Committee (Ministry of Health) and a Fellow of the Chapter of Urology (College of Surgeons, Academy of Medicine).  He had fellowship training in reconstructive urology and subsequently in minimally invasive urology. He participated as principal investigator in several international multi-centre clinical drug trials.  Current research includes collaboration with an academic tertiary institution, in the area of biomedical engineering.  He has a number of publications on various urological subjects in peer-reviewed journals.

Dr NG Chi Fai,Anthony
(HongKong SAR)

Dr Ng Chi Fai, Anthony graduated from the Chinese University of Hong Kong (CUHK) in 1993 and became an urologist in 2001. He spent one year in Scotland, worked under Mr David Tolley, for further training in endo-laparoscopic surgery and stone management.

He is currently a Professor of the Division of Urology, CUHK and the Course Director of the Robotic Surgery Training Programme, CUHK Hong Kong Jockey Club MIS Skill Centre. He has a wide range of interest, in particular in prostate diseases, urolithiasis, and promotion of men’s health. He was also honored with Outstanding Young Urologist Ward in 2010 by the Asian Congress of Urology, International Guest Scholar 2012 of the American College of Surgeons, and also Achievement Award from the World Chinese Urology Association 2014, as recognitions to his work in the field.

Besides clinical and research work, Dr Ng has also strong commitment in education and teaching. He is currently Council Member of the Hong Kong College of Surgeon and also board member of the Urology Board of the College. He have been awarded the Best Teacher Award (2008-2009, 2011-2012) of the Faculty of Medicine, the CUHK, for his contribution in undergraduate teaching.

Dr Caroline ONG

Dr Caroline Ong is a general pediatric surgeon with special interest in pediatric urology. After graduating from National University of Singapore, she completed Pediatric Surgery training in Singapore followed by subspecialty training in Pediatric Urology at the Royal Children’s Hospital in Melbourne. Her special interests in pediatric urology are antenatal hydronephrosis and neurogenic bladder.


Her other area of interest is medical education where she holds several educational leadership positions in postgraduate surgical training at institutional and national level. Her education interests are in surgical skills training and faculty development.

Dr TAN Yeh Hong

Dr Tan is the Senior Consultant Urologist at Mount Elizabeth Hospital, Singapore.


Professionally, Dr Tan serves as President of Singapore Urological Association.


Dr Tan graduated from National University of Singapore in 1991. Upon the completion of his advanced training / Urology Board Examination in 2002, he underwent further training Clinical Fellowship in Laparoscopy and Endourology at Duke University, USA (2002-2003). He also did a Preceptorship in Minimally Invasive Urology / Laparoscopic Surgery at Cleveland Clinic Foundation, USA (2003-2004).


Prior to his current practice, Dr Tan held the following positions at the Department of Urology, Singapore General Hospital: Director of Endourology, and Director of Laparoscopy & Robotic Surgery. He is currently a Visiting Consultant at the Singapore General Hospital.


He served as Senior Clinical Lecturer with the Yong Loo Lin School of Medicine, National University of Singapore and Adjunct Asst Professor with Duke – NUS Graduate Medical School. He was appointed as Visiting Professor to Capital Medical University, Beijing, China in 2008.


Dr Tan is the Editorial Board Member for International Journal of Urology and Journal of Minimally Invasive Urology. He has written various book chapters in international textbooks including Smith’s Textbook of Endourology and Hinman’s Atlas of Urologic Surgery.  He serves as Reviewer for various Journals. He has also been invited as International Faculty to give lectures in many countries, and perform Live Surgery Demonstration in the regions (China, Indonesia, Vietnam and Bangladesh).


Dr Tan has special interest in Minimally Invasive Surgery in the treatment of Urological Cancers – Robotic Surgery, and Laparoscopic Endoscopic Single Site Surgery (LESS) / Single Port Surgery.

Dr Ronny TAN

Dr Ronny Tan is a Consultant and Director of Andrology in the Department of Urology, Tan Tock Seng Hospital.

He underwent a 1-year SMSNA (Sexual Medicine Society of North America) accredited clinical fellowship training in Andrology, Sexual Medicine and Urologic Prosthetic Surgery at Tulane University, New Orleans, LA, USA, under the mentorship of Professor Wayne Hellstrom, making him the first Singaporean urologist to be fellowship-trained in this subspecialty in the USA.

He is a Clinical Core Faculty of the NHG-AHPL Urology Residency Program, an Adjunct Assistant Professor of the LKC School of Medicine, Nanyang Technological University and a Clinical Senior Lecturer of the YLL School of Medicine, National University of Singapore.

Dr Tan is currently in the Executive Committee of the Society for Men's Health, Singapore (SMHS) and Society for Continence Singapore (SFCS), Singapore Urological Association (SUA) and is a member of the Asia-Pacific Society for Sexual Medicine (APSSM) and International Society for Sexual Medicine (ISSM). He is a regular reviewer for the Journal of Sexual Medicine, Sexual Medicine Reviews and Urology (Gold Journal). He has served as course director in numerous symposia, masterclasses and shares his expertise as invited speaker and faculty in conferences in the region and abroad.

Dr Thomas Thamboo

Dr Thomas Thamboo is a Senior Consultant pathologist and Assistant Professor in the Department of Pathology, NUHS. He graduated from the medical school at the University of Leeds, United Kingdom in 1995. He trained in histopathology at the Department of Pathology, National University of Singapore, and obtained his specialist qualifications in histopathology from both the Royal College of Pathologists (United Kingdom) and the Royal College of Pathologists of Australasia in 2004. He undertook sub-specialty training in renal pathology at the department of cellular pathology at John Radcliffe Hospital, Oxford, United Kingdom in 2006.


He has authored or co-authored more than 50 papers in peer-reviewed journals and has contributed to a book chapter on the diagnosis of early gastric cancer. He is actively involved in general histopathology and cytopathology reporting, with sub-specialty interests in urologic pathology and renal pathology. He is also the Programme Director for the Pathology ACGME-I Residency Programme in NUHS.